Association between endostatin and mortality in patients with acute dyspnoea, with or without congestive heart failure: a single-centre, prospective, observational study
Endostatins are potential biomarkers for 3 months' mortality in patients hospitalised with CHF seeking emergency care with acute dyspnoea. Further studies are needed in different settings to assess the predictive value of endostatins in patients with CHF.
Authors
- Alireza Yaghoubi
- Per Wändell (ORCID: https://orcid.org/0000-0001-5169-2965)
- Axel Carl Carlsson (ORCID: https://orcid.org/0000-0001-6113-0472)
- Torgny Wessman (ORCID: https://orcid.org/0000-0002-7314-2240)
- Ardavan Khoshnood (ORCID: https://orcid.org/0000-0002-3142-4119)
- Caroline Heijl (ORCID: https://orcid.org/0000-0003-4276-3797)
Institutions
- Lund University (SE)
- Karolinska Institutet (SE)
- Skåne University Hospital (SE)
Publication Details
- Journal
- BMJ Open
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1136/bmjopen-2024-085238
- Primary Topic
- Inflammation biomarkers and pathways
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Göran Gustafssons Stiftelser
- Stiftelsen för Strategisk Forskning
- Lunds Universitet
- Knut och Alice Wallenbergs Stiftelse
- Novo Nordisk
- Vetenskapsrådet
- Skånes universitetssjukhus